HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon (NYSE:ACL), the world’s leader in eye care, announced today that it received regulatory approval and finalized the acquisition of the rights in the ...
Generic Durezol is a topical corticosteroid that is indicated for the treatment of inflammation and pain associated with ocular surgery, and the treatment of endogenous anterior uveitis. Dr. Reddy’s ...
Durezol had a market value of approximately $106 million for the 12-month period ended June 2021, according to IQVIA. The Food and Drug Administration has approved Cipla’s difluprednate ophthalmic ...
December 29, 2011 — The US Food and Drug Administration (FDA) is warning pharmacists about 2 drugs with similar brand names that could lead to a dispensing mistake and a seriously injured patient if ...
The US Food and Drug Administration (FDA) on Tuesday revised its draft bioequivalence (BE) guidance detailing the agency's expectations for generic versions of Durezol (difluprednate ophthalmic ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ...
HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon (NYSE: ACL), the world’s leader in eye care, announced today that it will purchase the rights in the United States for two FDA-approved topical eye care ...
TAMPA, Fla., Oct. 14 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today preliminary results from a pivotal anterior uveitis trial ...
Difluprednate Ophthalmic Emulsion 0.05% is an AB-rated generic equivalent of Durezol. Cipla announced that the Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application ...
The U.S. Supreme Court on Monday declined to consider a challenge to Federal Circuit Rule 36, which the U.S. Court of Apeals for the Federal Circuit uses to dispose of cases simply by saying the ...
SIRION THERAPEUTICS INC Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results